Aequs Board Approves ₹650 Crore Promoter Warrant Funding For Capacity Expansion

Market snapshot: Aequs Limited's Board of Directors has approved a preferential issue of warrants convertible into equity shares to its promoter group, Melligeri Private Family Foundation. The capital infusion will total ₹650 crore through up to 28,071,690 warrants priced at ₹231.55 each. This strategic move is aimed at expanding the company's aerospace and consumer manufacturing capacities while raising the promoter stake post-conversion.

Data Snapshot

• Total fundraise of ₹650 crore through up to 28.07 million warrants convertible into equity shares.
• Immediate upfront payment of ₹325 crore (50%) due at the time of subscription and allotment of the warrants.
• Warrant pricing fixed at ₹231.55 each, including a face value of ₹10 and a premium of ₹221.55.
• Expected rise in promoter group shareholding from 59.09% to 60.73% post-conversion of all warrants.

What's Changed

• Promoter equity stake is projected to grow by 1.64 percentage points assuming full warrant conversion.
• The business moves from a post-IPO debt reduction focus to a dedicated capacity expansion phase funded heavily by promoter group equity rather than new debt.

Key Takeaways

• Promoter Commitment: Melligeri Private Family Foundation's substantial ₹650 crore funding underscores strong long-term alignment and backing.
• Regulatory Surplus: The 50% upfront payment (₹325 crore) significantly exceeds the regulatory 25% minimum required under SEBI ICDR guidelines.
• Flexible Leverage: The remaining 50% balance can be converted into equity shares at any time on or before December 31, 2027.
• Capacity Target: The proceeds will specifically scale up highly complex aerospace precision manufacturing and consumer durable lines.

SAHI Perspective

The decision by Aequs' promoter group to inject ₹650 crore through convertible warrants is a high-conviction signal, especially given the capital-intensive nature of aerospace precision manufacturing. Crucially, the promoter foundation is putting up 50% of the subscription amount upfront (₹325 crore), which is double the regulatory minimum of 25% required under SEBI guidelines. This immediate liquidity is vital as Aequs continues to scale its aerospace order book, which recently crossed USD 1 billion, and transitions its toy and consumer electronics segments toward structural profitability.

Market Implications

The warrant issuance will lead to a minor dilution of public shareholding but strengthens Aequs' balance sheet without increasing debt. The incremental capital will directly fund the high-growth aerospace vertical (civil aviation components for Airbus, Boeing, Safran) and accelerate the scaling of the consumer durables and toy manufacturing units in their Special Economic Zones. Historically, high capital expenditure in these segments has weighed on earnings, so equity-funded growth is preferred over additional debt.

Trading Signals

Market Bias: Bullish

Strong promoter-led equity infusion of ₹650 crore, with ₹325 crore (50%) paid upfront. This significantly de-risks the capital structure, avoids debt-related interest pressure, and supports a USD 1 billion aerospace order book, justifying a positive outlook.

Overweight: Aerospace & Defense, Capital Goods, Precision Engineering

Trigger Factors:

• Shareholder voting approval at the upcoming EGM scheduled for October 22, 2026.
• Quarterly updates on the conversion of the USD 1 billion aerospace order book into actual serial production revenue.
• Financial breakeven timeline of the consumer electronics and toys divisions by early FY2027.

Time Horizon: Medium-term (3-12 months)

Industry Context

India's precision aerospace manufacturing sector is witnessing massive expansion, driven by global supply chain diversification and 'Make in India' initiatives. Aequs operates a fully vertically integrated aerospace ecosystem within a single SEZ in Belagavi, which covers forging, machining, and surface treatment. This structural moat positions the company well against peers in high-barrier aerospace component manufacturing. Funding capex via equity rather than debt is a key positive as the company scales to meet global OEM demand.

Key Risks to Watch

• Execution risk: Potential delays in ramping up consumer electronics production at the new Hubballi facility.
• Customer approvals: Delays in qualification of new aerospace components by global OEMs like Airbus or Boeing could postpone revenue realization.
• Dilution concern: Short-term equity dilution once the warrants are fully converted into shares before December 31, 2027.

Recent Developments

In Q1 FY2027, Aequs reported a 55% YoY revenue increase to ₹395.5 crore (derived from ₹3,955 million) from ₹255.57 crore, driven by a growing aerospace order book which has crossed USD 1 billion. The company also appointed Reenah Simon Joseph as Chief Financial Officer effective August 31, 2026, and dissolved its step-down subsidiary, Aequs Toys HongKong, on September 17, 2026.

Closing Insight

The ₹650 crore equity fundraise marks a pivotal moment for Aequs. By securing substantial promoter backing, the company is well-armed to capitalize on its massive aerospace order book while maintaining a strong balance sheet. Investors should monitor the upcoming EGM on October 22, 2026, and progress in the commercial scaling of their consumer segment.

High Performance Trading with SAHI.